Patients with acute decompensated heart failure had significantly higher mean levels of NT-proBNP (54.89 vs 23.921) and TNF-α (30.974 vs 10.2) compared to healthy controls.
Case-Control (n=90)
Sí
Are NT-proBNP and TNF-α levels elevated in patients with acute decompensated heart failure with reduced ejection fraction compared to healthy controls?
NT-proBNP and TNF-α levels are significantly elevated in patients with acute decompensated heart failure with reduced ejection fraction compared to healthy controls.
Abstract Background: In Western nations, acute decompensation of heart failure (ADHF) is the most frequent cause of hospitalization for people over the age of 65 years. Due to the high death rate, it places a heavy cost on both patients and the health care system. Objective: The investigation’s objective is to check the level of NT-proBNP and TNF- α and check if it is associated with heart failure (HF) with reduced ejection fraction (HFrEF). Materials and Methods: About 60 patients whose average age is 25–94 years were taken from both genders after the clinical diagnosis by a specialist to cases who were referred to the Ibn Al-Baitar Specialized Center for Cardiac Surgery and Ramadi Teaching Hospital, and 30 healthy people were taken as a control. The levels of NT-proBNP and TNF- α had been planned to be detected from the sera taken from the patients and controls by ELISA technique. Results: The mean level of NT-proBNP (54.89 ± 8.54) and TNF- α (30.974 ± 6.016) in patients were both significantly higher than those in controls (23.921 ± 4.051, 10.2 ± 2.386) respectively. Conclusion: This study showed that patients with ADHF had elevated levels of NT-proBNP and TNF- α .
Mohammed et al. (Thu,) conducted a case-control in Acute Decompensated Heart Failure with Reduced Ejection Fraction (n=90). NT-proBNP and TNF-α measurement vs. Healthy controls was evaluated on Levels of NT-proBNP and TNF-α. Patients with acute decompensated heart failure had significantly higher mean levels of NT-proBNP (54.89 vs 23.921) and TNF-α (30.974 vs 10.2) compared to healthy controls.